The newly launched Journal of Stem Cell and Regenerative Biology (JSRB) has taken off very well as great platform and is efficiently bringing together eminent academicians, researchers, scientists, medicos and members of the general public to discuss the many ways stem cells are being used: That is, in the labs, to basically serve the research programs aimed towards knowing the mechanistic/genetic pathways of how they work, and clinically, to develop possible treatments for patients with unmet medical needs. The field of Regenerative biology is paving way toward its major revolutionary expansion and maximum utilization in this post-genomic era, due to the availability of an amazing combo of various techniques, which indeed have presented the stem cells as valuable regenerative tools for damage repair. In recent times, the research involving human and animal stem cell preparations continues to be an extremely active area, since it is developing novel research tools, new knowledge about pathways of cell differentiation, consequently opening new vistas of cell transplantation therapy for human diseases. Stem cells directed to differentiate into specific cell types, offer immense possibility of a renewable source of replacement cells and tissues to treat diseases; including macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis, to name a few! Especially, research interventions using the human stem cell preparations hold enough promise for a) increased understanding of the basic molecular process underlying cell differentiation, b) improvised perception of the early stages of genetic diseases and possibly cancer, and c) future cell transplantation therapies for various human diseases. Whether it is the beating of human heart cells growing in synchrony in a petri-dish, or the development of eye-cells in the lab, or the recent innovation of the genetically reprogrammed induced pluripotent stem cells (iPS cells), the scientists now have the essential skills, better handle and technology (Regenerative medicine) to generate human stem cell models of cardiomyopathy (heart disease) and many other diseases like diabetes, Alzheimer’s, Parkinsons Disease etc in a dish. Researchers in this area also are very much aware that turning genes “on and off” is central to this process, which renders a great handle to manipulate the “blank slates-stem cells” according to the need of the hour and patients in question (Tailor-made stem cells). Knowing the various potential applications of human stem cells in the generation of cells and tissues that could be used for the cell-based-therapies, there’s a far more pressing reason to expand our knowledge and keep abreast with the newest updates and interventions in this area of research and therapy. The Journal of Stem Cell and Regenerative Biology is working towards this great cause and we definitely strive to do better in near future!
Aim & Scope
Journal of Stem Cell and Regenerative Biology is established with a focus to publish high quality open access, peer review articles in the field of stem cells Biology. Journal covers all aspects of stem cell biology including embryonic stem cells, adult stem cells, induced pluripotent stem cells, autologous adult stem cells, umbilical cord blood cells, bone marrow stem cell, fetal stem cells, hematopoietic stem cell, cancer stem cells, cell-based regenerative therapies, stem cell transplantation, reconstitution in vivo, regenerative medicine, translational research also the physiology, genomics, epigenetics, proteomics, metabolomics of stem cells. Ommega publishers encourage and welcome investigators to share their Original articles, Review articles, Short reports, Communications, Editorials, to bring awareness about the advancements in the stem cell related therapies so that the readers receive complete information about the topic. Ommega Publishers aims in rapid publication process, dedicated Editorial Board, minimum publication charges, leading database indexing, copyrights, quick assistance, and feasible publishing model. Our well organized Editorial board members and reviewers act as a backbone to whole process of publication, all manuscripts are monitored using online tracking system, and Editors decision is supreme in the event of accepting, rejecting, changes and modifications of manuscript.
Journal of Stem Cell and Regenerative Biology accept the articles from various aspects of stem cells • Embryonic stem cells • Induced pluripotent stem cells • Tissue-specific stem cells • Cancer stem cells • Translational Clinical research • Regenerative medicine • Endometrial stem cells in regenerative medicine • Genes & Microenvironment • Cell-Based Therapies • Hematopoietic Stem Cell • Stromal Cell • Stem cells for treatment of macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.
Ommega Publishers sincerely believes and charges reasonably in other words it is one of the publishers that provides a platform which charges economically towards the publication charges so that there are no barriers for free and fruitful knowledge sharing. Ommega Publishers have also classified their charges as defined by the World Bank Country Classification table: High Income countries, Middle Income countries and Low Income countries
Ommega journals are Open Access and do not receive any funding, we solely depend on Authors through membership fees, and article processing charges to meet the expenses like managing the team of Editorial experts and professionals to advance and support needs arising in the fields of editorials boards,marketing and IT, peer reviewing of the articles,editing of articles, developing and maintaining the software and information technology, updating the journal website, archiving of the articles and other costs associated concerning to maintain global standards of Publishing.
Ommega publishers believes and maintains high quality of services and articles through this model each and every manuscript that is accepted attract publication charges.Ommega publishers does not support any hidden costs, charge for color figures,as well as does not charge any additional fees for all the authors worldwide.
If for some reason, Researcher/ Author is unable to pay the processing charges, they can submit their applications citing the reasons for a waiver or discount to email@example.com before or immediately after submitting their article.
Waivers are calculated on the Article processing fees of the related Journal after the submission and acceptance of the manuscript.
"Article Publishing Charges"charged by Ommega Online Publishers for publishing manuscripts are as follows.
SC=Short communication MR=Mini review CR= Case report RA = Review Article/ Research Article Note:The prices and guidelines mentioned above are subject to change without prior notice.
Embryonic stem cells, Induced pluripotent stem cells, Tissue-specific stem cells, Cancer stem cells, Clinical research and regenerative medicine, Endometrial stem cells in regenerative medicine